Dr Timothy Harlan, also known as Dr Gourmet, talks about his session at Consultant's Cardiometabolic Risk Summit this year, the Mediterranean diet, and culinary medicine.
Dr Steven Nissen from Cleveland Clinic talks to us about intravascular ultrasound technology as well as different trials that assessed BP lowering techniques.
<p>In part 1 of this 4-part series, Dr Paul Mather from the Perelman School of Medicine talks about how to select and manage patients with end-stage heart failure.</p>
<p>Margo Minissian,&nbsp;PhD, ACNP, from the Cedars-Sinai Heart Institute discusses her session about non-statin therapies for lowering cholesterol, which she will be presenting at Consultant's...
<p>Dr Michael Bloch from Blue Spruce Medical Consultants talks about the ACP's new hypertension guidance, the new "prehypertension" group of patients,&nbsp;and more.</p>
Daniel Einhorn, MD, from Scripps Whittier Diabetes Institute talks about the "debate of 2018": ACP's new guidance on controlling HbA1c levels in adults with diabetes.
Dr Seth Baum interviews Dr Mikhail Kosiborod about clinical trial data surrounding the possible mechanisms of action of SLGT2 inhibitors for heart failure, as well as the cardio-renal connection.
Dr Peter Jones from Houston Methodist Hospital discusses cardiovascular disease and lipids, topics in which he is speaking about during Consultant360's Cardiometabolic Risk Summit this year.
Dr James Januzzi from Massachusetts General Hospital discusses the new consensus statement on heart failure, biomarker testing for diagnosing heart failure, and potential future treatments.
